NCT00690391

Brief Summary

The purpose of this study is to define if palliative surgery in patients with cancer improves quality of life and prognosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

May 30, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2008

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

June 4, 2008

Status Verified

May 1, 2008

Enrollment Period

1 year

First QC Date

May 30, 2008

Last Update Submit

May 30, 2008

Conditions

CancerQuality of Life

Keywords

surgeryprognosticpalliation

Study Arms (1)

Surgical observation

patients with cancer in a palliative setting and in need of surgical interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with plannes surgery and cancer in he University hospital Frankfurt

You may qualify if:

  • clinical diagnosis of inoperable cancer
  • planned surgery
  • able to give interview
  • written informed consent

You may not qualify if:

  • unconsciousness
  • psychiatric disorder
  • not able to communicate in German

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University hospital Frankfurt

Frankfurt, 60590, Germany

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Christoph Wullstein, PD DR.

    Goethe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christoph Wullstein, PD Dr.

CONTACT

+49696301Christoph.Wullstein@kgu.de

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 30, 2008

First Posted

June 4, 2008

Study Start

May 1, 2008

Primary Completion

May 1, 2009

Study Completion

May 1, 2013

Last Updated

June 4, 2008

Record last verified: 2008-05

Locations

DE(1)